SCHEMBL6000629

SCHEMBL6000629

CC1(C)CCC(c2ccc(CCNc3ccc(-c4csc(CCNS(=O)(=O)c5ccc(C(=O)O)cc5)n4)cc3)cc2)CC1

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ADRB3 P13945 10/20 0.40
PHGDH O43175 4/20 0.38
POLB P06746 3/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C19 P33261 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
GPR55 Q9Y2T6 1/20 0.36
ALDH1A1 P00352 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
ADRB2 P07550 1/20 0.35
ADRB1 P08588 1/20 0.35
MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5999085 0.92 ADRB3 (0.41) ADRB3PHGDHPOLBMEN1KMT2A
SCHEMBL6000624 0.87 TRPM8 (0.40) ADRB3POLBMEN1KMT2ANPC1
SCHEMBL6000038 0.87 MEN1 (0.40) ADRB3POLBMEN1KMT2ANPC1
SCHEMBL5999747 0.85 OPRM1 (0.41) ADRB3PHGDHPOLBMEN1KMT2A
SCHEMBL6000818 0.84 MEN1 (0.38) ADRB3POLBMEN1KMT2ANPC1
SCHEMBL6001067 0.83 RAB9A (0.42) POLBMEN1KMT2ANPC1RAB9A
SCHEMBL6000702 0.83 AKR1C3 (0.47) ADRB3POLBMEN1KMT2ACYP2C19
SCHEMBL5999078 0.80 AVPR1B (0.42) ADRB3POLBMEN1KMT2ANPC1
SCHEMBL5999739 0.79 MRE11 (0.40) ADRB3POLBMEN1KMT2ANPC1
SCHEMBL6000034 0.79 MEN1 (0.38) ADRB3POLBMEN1KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-06-08 US claimed
EP-1553091-A1 HETEROAROMATIC PENTACYCLIC COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2005-07-13 EP claimed
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-06-08 US disclosed
EP-1553091-A1 HETEROAROMATIC PENTACYCLIC COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2005-07-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof PTPN11, PTPN1, PTPN3 ADRB3 483/4885PHGDH 694/4885POLB 3893/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.